Christopher Bunka - Oct 26, 2023 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Signature
/Chris Bunka/
Stock symbol
LEXX
Transactions as of
Oct 26, 2023
Transactions value $
$0
Form type
4
Date filed
10/30/2023, 12:30 PM
Previous filing
Oct 18, 2022
Next filing
May 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 274K Oct 26, 2023 Direct
holding LEXX common shares 254K Oct 26, 2023 Private Holding Company

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +30K +29.7% $0.00 131K Oct 26, 2023 Common Shares 30K $1.15 Direct
holding LEXX Warrants 6.67K Oct 26, 2023 Common Shares 6.67K $10.50 Private Holding Company
holding LEXX Stock Options 32.7K Oct 26, 2023 Common Shares 26K $3.00 Direct F1
holding LEXX Stock Options 56K Oct 26, 2023 Common Shares 23.3K $3.00 Direct F2
holding LEXX Stock Options 71K Oct 26, 2023 Common Shares 15K $3.00 Direct F3
holding LEXX Stock Options 101K Oct 26, 2023 Common Shares 30K $2.91 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Repriced from $5.83 pursuant to shareholder approval received on May 9, 2023
F2 Repriced from $7.08 pursuant to shareholder approval received on May 9, 2023
F3 Repriced from $6.23 pursuant to shareholder approval received May 9, 2023